Quijano, Melven T.
HRN: 21-55-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
CEFUROXIME 500MG (TAB)
07/28/2026
08/03/2026
PO
500mg
Q12h
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: